Meniu
Asmeninė anketa Prisijungimas ir registracija
Atgal Pagrindinis » Autorių straipsniai » Medical Health » 2020 » Spalio » 17

Drug repurposing: Researchers find existing medications may fight coronavirus infection

Drug repurposing: Researchers find existing medications may fight coro
  • 17.10.2020
  • 0.0 Reitingas
  • 318 Peržiūrų
  • Aptarti

University of New Mexico researchers who combed through a "library" of previously approved drugs believe they have identified a medication with the potential to help speed a patient's recovery from SARS-CoV-2 infection.

"The gist of it is we think we found a drug that is on par with remdesivir and is much cheaper," said Tudor Oprea, MD, Ph.D., professor of Medicine and Pharmaceutical Sciences and chief of the UNM Division of Translational Informatics. Remdesivir is a relatively new antiviral medication that has been shown to shorten hospital stays for those recovering from the novel coronavirus.

In a paper published this week in ACS Pharmacology & Translational Science, Oprea and his colleagues, in partnership with a team at the University of Tennessee Health Science Center led by professor Colleen Jonsson, Ph.D., reported that an older antimalarial drug called amodiaquine was effective in eradicating the virus in test tube experiments.

Tudor Oprea, MD, Ph.D.It was one of three promising candidates identified in a process that entailed studying the molecular characteristics of about 4,000 drugs approved for human use by the Food and Drug Administration and other agencies. The researchers hoped to find drugs that would target known vulnerabilities in the virus.

The other two drugs—an anti-psychotic called zuclophentixol and a blood pressure medication called nebivolol also cleared the virus in the experiments, said Oprea, who served as the corresponding author on the new paper. The researchers think any of these three drugs could be combined with remdesivir or a related antiviral drug called favipiravir to mount a more potent attack on the virus.

Combining two drugs could mean that lower doses of each could be administered, lessening the likelihood of adverse reactions, he said.s Administering two drugs also makes it less likely that the virus would develop a mutation rendering it immune from the treatment.

"Think of it as a whack-a-mole game," Oprea said. "Instead of having one hammer, you have two hammers, which is more effective. We're trying to give the scientific community two hammers instead of one."

Many compounds that show antiviral activity in a laboratory setting don't have the same effect in living organisms, Oprea notes, so the next step is to mount clinical trials to see whether the medications work in COVID-positive patients.

The UNM drug screening process started with Oprea and his colleague Larry Sklar, Ph.D., Distinguished Professor in the Department of Pathology. They used computational methods to identify candidate drugs by gauging their similarity to hydroxychloroquine, a since-discredited antimalarial medication that had been widely touted as a COVID-19 treatment. Because of molecular variations in some of the drugs, more than 6,000 combinations were assessed.

Likely candidates were forwarded to Steven Bradfute, Ph.D., assistant professor in the Center for Global Health, who tested the compounds against samples of the virus in his Biosafety Level-3 laboratory. Later, the experiments were repeated by the University of Tennessee scientists to provide independent confirmation of the findings—and they used an additional test that reveals the drugs' potency against the virus, Oprea said.

Amodiaquine, first made in 1948, is on the World Health Organization's List of Essential Medicines. It has a good safety profile and is widely used in Africa to treat malaria. Zuclophentixol has been used to treat schizophrenia since the 1970s, while nebivolol has been used for hypertension since the late 1990s.

by University of New Mexico

Image of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDC

Turite savo nuomone, tapk autoriumi, prisijunk ir rašykite bloge. Dalinkitės receptais, sveikatos patarimais, nutikimais, susidūrėte su nekasdieniškais reiškiniais. Galite išversti iš užsienio kalbos, talpinkite su nuoroda. Laukiame Jūsų straipsnių, naujienų, apžvalgų ar istorijų!

Naujausias Pasaulio naujienas kitaip... skaitykite Paranormal Telegram kanale. Jei manai, kad mano darbas yra naudingas, pasidalink, prenumeruok, padėkok ar paremk...

Niekas neišdrįso palikti komentaro.
Būkite pirmi, kurie pasidalins savo nuomonėmis su kitais.
avatar

Nemokami skelbimai

TAIP PAT SKAITYKITE:
22.09.2023 laikas 09:04 Tauta Siūlo Kodėl valdžia viešai nebesiskiepija?
Žmonės jau buvo linkę pamiršti kovidą ir su juo susijusias problemas bei ribojimus, tačiau pastaruoju metu įvairūs ekspertai vėl pradėjo gąsdinti, kad jeigu dar ne rudenį, tai žiemą virusas tikrai smogs.

Skaityti daugiau

22.09.2023 laikas 08:44 Tauta Siūlo Papiktino atmintinos vietos pavadinimas
Nurodoma, kad tai „Lietuvos partizanų užkasimo vieta“. Savo nuomonę išsakęs ukmergiškis svarsto, kodėl parinktas toks keistas, niekur negirdėtas terminas. „Negi negalima buvo kaip nors kitaip pagarbiau pavadinti“, – piktinosi jis....

Skaityti daugiau

22.09.2023 laikas 08:39 Tauta Siūlo Dėl praleisto skambučio liko be vaistų

Ponia Danutė liko nusivylusi nuotolinių konsultacijų pas medikus tvarka – dėl praleisto skambučio mėnesį liko be vaistų.

Skaityti daugiau

26.09.2023 laikas 20:01 Klausas Schwabas pripažįsta, kad Darbotvarkė iki 2030 m. žlunga, nes milijonai žmonių sukilo prieš naująją pasaulio tvarką
Prieš dvejus metus Klausas Schwabas (Klausas Švabas) atvirai pareiškė, kad 2030 m. Pasaulio ekonomikos forumas visiškai kontroliuos žmoniją.

Skaityti daugiau

26.09.2023 laikas 08:49 Skiepijimas "nesuteikia jokios reikšmingos apsaugos" nuo ilgo COVID: tyrimas

Naujo tyrimo išvados paneigia vyraujančią nuomonę, kad skiepai nuo COVID-19 apsaugo nuo ilgojo COVID. Tyrimo metu nustatyta, kad nors ankstesni užsikrėtimo atvejai 86 proc. sumažina ilgosios COVID riziką, skiepijimo būklė prieš užsikrėčiant COVID ...

Skaityti daugiau

25.09.2023 laikas 21:36 Dirbtinė laimė – XXI amžiaus priklausomybė
Kai turi brangią mašiną, gražių daiktų, prabangų namą ir kitų statuso simbolių, pradedi jaustis, tarsi turi didesnę vertę ir pakyli vienu lygiu aukščiau už tuos, kurie viso to neturi.

Skaityti daugiau